Company Profile

Thronebiotechnologiesthroneis A Clinical Stagetherapeutic Company With A Disruptivestem Cell Technology That Can Fundamentally Reversetype1 Diabetest1D Alopecia Areataaaand Other Autoimmunediseases Through Immuneeducation Of Stem Cell Educator Therapy Educator Therapy At Theroot Causesover Last 10 Yearsinternational Multicenter Clinical Trials In Spainchinaand Theunited States Havestrongly Demonstrated Theclinical Safety And Efficacy Of Educator Therapy In Morethan 200 Patients Aged From To 70 Years Oldcurrentlythronehas Received Threefda Approved Phase2 Inds By Using Educator Therapy To Treat T1Daaand Severecovid 19 Patientsspecificallyour Globally Patented Technology Is Recognized As Theleadingpractical Cureprojectfor T1D Out Of 590 Global Projectsjuvenilediabetes Curealliancejdca2021New York T1D Is A T Cellaemediated Autoimmunediseasethat Causes A Deficit Of Islet Beta Cellsmillions Of Individuals Worldwidehavet1Dand Incidenceincreases Markedly Sincecovid 19 Pandemic Startedrecent Clinical Trials Havehighlighted Thelimits Of Conventional Immunetherapy And Underscoretheneed For Novel Approaches That Not Only Overcomemultipleimmunedysfunctionsbut Also Help Restoreislet Beta Cell Functionto Address Thesetwo Key Issuesthronehas Developed A Uniqueand Novel Educator Therapy By Using A New Typeof Cord Blood Derived Multipotent Stem Cellscb Sc With This Patented Technologya Patient S Blood Is Circulated Through A Blood Cell Separatorwherethepatient S Immunecells Areco Cultured With Adherent Cb Sc In Vitroand Returnseducatedimmunecells To Thepatient S Circulationnotablyeducator Therapy Is Theonly Therapy To Dateto Safely And Efficiently Correct Autoimmunity And Restorebeta Cell Function In T1D Patients